309 related articles for article (PubMed ID: 28455785)
1. Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis.
Ferreira ACM; Marson FAL; Cohen MA; Bertuzzo CS; Levy CE; Ribeiro AF; Ribeiro JD
Lung; 2017 Aug; 195(4):431-439. PubMed ID: 28455785
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis.
Ho SA; Ball R; Morrison LJ; Brownlee KG; Conway SP
Pediatr Pulmonol; 2004 Jul; 38(1):82-7. PubMed ID: 15170878
[TBL] [Abstract][Full Text] [Related]
3. Early detection of non-tuberculous mycobacteria in children with cystic fibrosis using induced sputum at annual review.
Ahmed MI; Kulkarni H; Shajpal S; Patel D; Patel P; Claydon A; Modha DE; Gaillard EA
Pediatr Pulmonol; 2019 Mar; 54(3):257-263. PubMed ID: 30561865
[TBL] [Abstract][Full Text] [Related]
4. The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial.
Ronchetti K; Tame JD; Paisey C; Thia LP; Doull I; Howe R; Mahenthiralingam E; Forton JT
Lancet Respir Med; 2018 Jun; 6(6):461-471. PubMed ID: 29778403
[TBL] [Abstract][Full Text] [Related]
5. Safety and use of sputum induction in children with cystic fibrosis.
Suri R; Marshall LJ; Wallis C; Metcalfe C; Shute JK; Bush A
Pediatr Pulmonol; 2003 Apr; 35(4):309-13. PubMed ID: 12629630
[TBL] [Abstract][Full Text] [Related]
6. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis.
Singh S; Hornick D; Fedler J; Launspach JL; Teresi ME; Santacroce TR; Cavanaugh JE; Horan R; Nelson G; Starner TD; Zabner J; Durairaj L
J Cyst Fibros; 2020 Jan; 19(1):108-113. PubMed ID: 31327670
[TBL] [Abstract][Full Text] [Related]
8. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
9. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
10. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
[TBL] [Abstract][Full Text] [Related]
11. Induced sputum in young healthy children with cystic fibrosis.
Forton J
Paediatr Respir Rev; 2015 Oct; 16 Suppl 1():6-8. PubMed ID: 26410282
[TBL] [Abstract][Full Text] [Related]
12. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.
Tunney MM; Field TR; Moriarty TF; Patrick S; Doering G; Muhlebach MS; Wolfgang MC; Boucher R; Gilpin DF; McDowell A; Elborn JS
Am J Respir Crit Care Med; 2008 May; 177(9):995-1001. PubMed ID: 18263800
[TBL] [Abstract][Full Text] [Related]
13. Sputum induction improves detection of pathogens in children with cystic fibrosis.
Hoppe JE; Towler E; Wagner BD; Accurso FJ; Sagel SD; Zemanick ET
Pediatr Pulmonol; 2015 Jul; 50(7):638-46. PubMed ID: 25565628
[TBL] [Abstract][Full Text] [Related]
14. Induced sputum in the very young: a new key to infection and inflammation.
Mussaffi H; Fireman EM; Mei-Zahav M; Prais D; Blau H
Chest; 2008 Jan; 133(1):176-82. PubMed ID: 17989149
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
[TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
[TBL] [Abstract][Full Text] [Related]
17. Timing of hypertonic saline inhalation for cystic fibrosis.
Elkins M; Dentice R
Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
[TBL] [Abstract][Full Text] [Related]
18. Hypertonic saline for cystic fibrosis: worth its salt?
Goralski JL; Donaldson SH
Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113
[TBL] [Abstract][Full Text] [Related]
19. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
Al-Aloul M; Nazareth D; Walshaw M
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
[TBL] [Abstract][Full Text] [Related]
20. Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis.
Fenn D; Abdel-Aziz MI; Brinkman P; Kos R; Neerincx AH; Altenburg J; Weersink E; Haarman EG; Terheggen-Lagro SWJ; Maitland-van der Zee AH; Bos LDJ;
J Cyst Fibros; 2022 Jan; 21(1):52-60. PubMed ID: 34548223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
